[
mrna vaccine
]
Money, talent flowing into mRNA research after Covid-19 success
Reuters |
PUBLISHED ON MAR 15, 2021 04:29 PM IST
Billions of dollars in capital have flowed into mRNA-focused companies based on raised expectations
India’s mRNA vaccine candidate advances to human trial phase
New Delhi, Hindustan Times | By Anonna Dutt
UPDATED ON DEC 12, 2020 02:56 PM IST
An mRNA vaccine uses a synthetic RNA (genetic material) encoded with instructions to make specific proteins of the Sars-CoV-2 virus so that the body can generate an immune response without getting the disease.